Articaine
- Generic Name
- Articaine
- Brand Names
- Articadent, Astracaine, Orabloc, Septanest, Septocaine, Ultacan, Ultracaine, Zorcaine
- Drug Type
- Small Molecule
- Chemical Formula
- C13H20N2O3S
- CAS Number
- 23964-58-1
- Unique Ingredient Identifier
- D3SQ406G9X
- Background
Articaine is a dental local anesthetic. Articaine is widely used around the world and is the most popular local anesthetic in many European countries.
- Indication
适用于牙槽外科、牙髓治疗、牙体预备级黏膜切开等口腔手术麻醉。
- Associated Therapies
- Dental Local Anesthesia
A Safety Study of of AG-920 Sterile Topical Ophthalmic Solution
- First Posted Date
- 2022-08-16
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- American Genomics, LLC
- Target Recruit Count
- 249
- Registration Number
- NCT05501860
- Locations
- 🇺🇸
American Genomics Site 1, Newport Beach, California, United States
🇺🇸American Genomics Site 2, McAllen, Texas, United States
Self-Reported Pain in Children Submitted to Single Infiltration of Articaine During Primary Molar Extraction
- First Posted Date
- 2022-07-05
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Universidade Federal de Santa Catarina
- Target Recruit Count
- 76
- Registration Number
- NCT05443009
- Locations
- 🇧🇷
Centro de Especialidades Odontológicas (CEO), São José, Brazil
🇧🇷Universidade Federal de Santa Catarina - USFC, Santa Catarina, Brazil
A Study of Safety and the Local Anesthetic Effect of AG-920 Ophthalmic Solution in a Pediatric Population
- First Posted Date
- 2022-04-13
- Last Posted Date
- 2023-10-25
- Lead Sponsor
- American Genomics, LLC
- Target Recruit Count
- 61
- Registration Number
- NCT05325853
- Locations
- 🇺🇸
American Genomics Site 2, McAllen, Texas, United States
Uterovaginal Plexus Block With Articaine for Intrauterine Device Placement Patients Who Are Indicated for the Use of Copper IUD as a Contraceptive Method Will be Invited to Participate in This Research.
- Conditions
- ContraceptionIUDAnesthesia, Local
- Interventions
- First Posted Date
- 2022-02-23
- Last Posted Date
- 2022-02-23
- Lead Sponsor
- Universidade do Vale do Sapucai
- Target Recruit Count
- 240
- Registration Number
- NCT05252117
- Locations
- 🇧🇷
Universidade do Vale do Sapucaí, Pouso Alegre, Minas Gerais, Brazil
Articaine Versus Lidocaine Buccal Infiltration
- Conditions
- Pain
- Interventions
- First Posted Date
- 2022-02-03
- Last Posted Date
- 2023-02-15
- Lead Sponsor
- Fayoum University
- Target Recruit Count
- 31
- Registration Number
- NCT05223075
- Locations
- 🇪🇬
Fayoum University, Fayoum, Egypt
Local Anesthesia With Lidocaine or Articaine for Molars Affected by MIH
- Conditions
- Molar Incisor Hypomineralisation
- Interventions
- First Posted Date
- 2022-01-21
- Last Posted Date
- 2022-07-15
- Lead Sponsor
- Tishreen University
- Target Recruit Count
- 20
- Registration Number
- NCT05200884
- Locations
- 🇸🇾
Tishreen University, Latakia, Syrian Arab Republic
Articaine 4% Efficacy and Safety in Extraction and Pulpotomy of Primary Molars of Children Below the Age of Four Years
- Conditions
- PainBehavior
- Interventions
- Drug: Lidocain hydrochloride 2 % with epinephrine
- First Posted Date
- 2021-11-01
- Last Posted Date
- 2021-11-01
- Lead Sponsor
- Mahmoud Ahmed Mahmoud
- Target Recruit Count
- 292
- Registration Number
- NCT05101785
Buzzy System Compared to Topical Anaesthesia During Infiltration Injection in Children.
- Conditions
- Local Anaesthesia
- Interventions
- Drug: Topical anestheticDevice: Buzzy System
- First Posted Date
- 2021-10-19
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Cairo University
- Target Recruit Count
- 70
- Registration Number
- NCT05083975
- Locations
- 🇪🇬
Faculty of dentistry, Cairo University, Cairo, Manial, Egypt
A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution
- First Posted Date
- 2021-04-02
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- American Genomics, LLC
- Target Recruit Count
- 120
- Registration Number
- NCT04829344
- Locations
- 🇺🇸
American Genomics Site 2, McAllen, Texas, United States
Anaesthetic Efficacy of 2% Mepivacaine Versus 4% Articaine With Symptomatic Irreversible Pulpitis
- Conditions
- Symptomatic Irreversible Pulpitis
- Interventions
- First Posted Date
- 2021-03-30
- Last Posted Date
- 2021-08-02
- Lead Sponsor
- Cairo University
- Target Recruit Count
- 330
- Registration Number
- NCT04822415
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.